从植入前遗传学诊断异常的胚胎中分离人胚胎干细胞系

在体外受精过程中,通过胚胎植入前遗传性诊断（PGD）对有遗传风险患者的胚胎进行植入前活检和遗传学分析,选择无遗传性疾病的胚胎植入子宫,而PGD诊断异常的胚胎则会被丢弃。本研究尝试将PGD异常胚胎用于分离人胚胎干细胞,以获得携带遗传缺陷的人胚胎干细胞系。利用荧光原位杂交技术对第3-5天胚胎进行PGD检测,结果异常的胚胎进一步用于分离获取胚胎干细胞系,然后对h ES细胞系进行核型及干细胞表面标记、多能性基因表达、端粒酶活性以及分化能力等特征性鉴定。总共从13个PGD异常胚胎中分离获得8个人胚胎干细胞系,建系效率为61.5%,其中1个核型正常,5个核型异常。说明利用PGD异常胚胎可以获得携带遗传缺陷的人胚胎干细胞系,不仅为评估PGD技术临床结论的准确性提供了一种新方法,更重要的是为研究各种遗传性疾病的发病机理提供了有效的细胞模型。     

21三体综合症植入前诊断的临床前运用研究

探讨建立一个高效、稳定的21三体遗传病植入前诊断的方法,以染色体G显带核型分析为对照,取正常成人外周血单个淋巴细胞40枚、21三体患者外周血单个淋巴细胞40枚及单卵裂球20枚,采用荧光定量PCR技术同时扩增21号染色体上特异区域基因片段(DSCR)和12号染色体上管家基因(GAPDH)片断作内对照,结果在正常组织同时扩增二片断的有效率为95%(38/40),扩增产物的荧光强度比值为1.00±0.05;21三体患者单个淋巴细胞同时扩增二片断的有效扩增率为92.5%(37/40),DSCR/GAPDH荧光强度的比值约为1.58±0.17;单卵裂球的扩增效率为80.0%(16/20).三者实验结果与染色体核型分析结果完全一致,准确率100%.研究结果表明荧光定量PCR技术产前检测21三体综合征具有准确、快速、安全、实用等特点,有较高的临床推广应用价值.     

运用PCR对小鼠植入前胚胎进行性别诊断

根据C57BL6小鼠Y染色体重复序列145C5的碱基顺序,设计并合成一对引物,运用PCR扩增昆明白小鼠入前胚胎卵裂球DNA,以确定其性别,共对108枚活检胚胎的相应卵裂球进行了性别诊断,获雄性胚46枚,雌性胚62枚,移植后分别获雄性仔鼠4只,准确率100％（4／4）,雌性仔鼠9只,准确率70％（9／13）,本研究结果表明小鼠Y染色体重复序列145C5的碱基顺序在C57BL6小鼠和昆明白小鼠中基本一致,为农牧业动物进行性别选择和运用PCR进行单基因病植入前遗传学诊断提供了方法学基础。     

单细胞单轮二重PCR诊断X-连锁鱼鳞病

X-连锁鱼鳞病(X-linked ichthyosis,XLI)是隐性遗传病.是人类最常见的先天性代谢疾病之一.从单细胞水平诊断XLI,就可为开展XLI的胚胎植入前遗传学诊断(preimplantation genetic diagnosis,PGD)打下基础.采用单轮二重PCR扩增患者和正常女性的单淋巴细胞以及正常人单卵裂球的STS基因和amelogenin(Amel)基因,在正常人单淋巴细胞组和正常人单卵裂球组中STS基因扩增成功率分别为95.8%、90.9%,在患者单淋巴细胞组中的假阳性率为1.5%:在Amel-X和Amel-Y基因位点扩增成功率分别为91.9%、92.7%,污染率分别为1.4%、0;ADO的发生率为6.2%.结果表明单细胞单轮二重PCR诊断XLI具有较高的准确性和特异性,有助于我们进一步开展XLI的PGD.     

筛选代表小鼠植入前胚胎紧密化相关基因的EST

分别收集181及241枚昆明白小鼠8细胞早期胚胎及8细胞紧密化胚胎,采用SMART PCR方法直接合成胚胎双链cDNA。进而运用抑制消减杂交技术（SSH）对8细胞早期胚胎及8细胞紧密化胚胎的基因表达进行研究,并将所获得的差异表达产物按片段大小分段分离纯化后克隆入pUCm-T载体中,经PCR鉴定后挑选阳性克隆进行测序,筛选出27个代表8细胞早期胚胎和紧密化8细胞胚胎差别表达基因的cDNA片段;经与GenBank中收录的序列进行同源性匹配分析,证实其中17个cDNA片段为新的EST,提交GeneBank后被接受并给予了新序列编号。这17个片段均可能为与紧密化密切相关的新基因的表达片段,为进一步克隆新的紧密化相关基因的全长cDNA及后续新基因的结构和功能研究打下基础。通过采用不同长度大小片段分别克隆的方法,可获得较长片段的EST,避免差异表达大片段的丢失。Abstract: A total of 181 8-cell embryos and 241 8-cell compacted embryos were collected respectively from Kunmingbai mouse and their cDNA was synthesized directly using SMART PCR. Genes, which expressed differently between early 8-cell embryos and 8-cell compacted embryos, were investigated using the method of suppression subtractive hybridization (SSH). Then PCR production was cloned into pUCm-T vector respectively according to the size after isolated and purified. Twenty-seven ESTs (expressed sequence tags ) of genes expressed differently between early 8-cell embryos and 8-cell compacted embryos have been isolated and cloned. seventeen of those were novel ESTs after being confirmed by blaster matching in GenBank for homology analysis. And they were banked into GenBank with accession numbers. All 17 ESTs might be for novel genes related to compaction in compacted embryos. And longer ESTs may be obtained by cloning according to the size.     

荧光原位杂交探针应用于平衡易位t（1，6）（q42；p23）胚胎植入前诊断的研究

背景：染色体相互易位在人群中比较常见,下一代常常产生相同或不同的易位,易导致容易流产,而植入前诊断方法之一的CGH难以检测到相互易位,因此原位杂交（FISH）依然是解决诊断相互易位的有力手段。目的：通过设计个体化的FISH探针,制备探针,并在卵裂球单细胞水平进一步验证探针的准确性,为筛选正常核型的囊胚进行植入奠定技术基础,为个体化的FISH探针植入前诊断提供应用研究基础。方法：通过设计1 q和6p平衡易位探针,进行探针标记,再采用患者和正常人核型验证探针质量,通过荧光原位杂交技术进一步检测正常人受精后的卵裂球中1q 和6p平衡易位对易位染色体状态。结果：3个卵接球裂均呈现单个完整细胞核,荧光原位杂交中各细胞核均有清晰明亮的杂交信号。信号数分别为2。均为正常胚胎,可以考虑进一步对该易位患者进行卵裂球进行诊断,上述研究对个体化的易位探针的应用研究提供了研究基础。     

不良孕产夫妇着丝粒-动粒复合体的细胞遗传学研究

为研究不良孕产夫妇染色体着丝粒-动粒复合体(centromerekinetochorecomplex,CKC)变异与不良孕产的相关性,探索不良孕产中非整倍体形成的细胞遗传学基础,应用改良的着丝粒点-核仁组织区(Cd-NOR)同步银染技术,分别对53对不明原因的不良孕产夫妇和57对已生育正常儿的正常夫妇外周血淋巴细胞染色体CKC变异类型及频率进行研究和分析.结果发现,不良孕产夫妇其小Cd、Cd消失、Cd迟滞和Cd-NOR融合频率均较正常对照组明显增高,两者相比有显著性差异(P＜0.05).CKC变异频率增高可能是导致不良孕产非整倍体形成的主要原因之一。 Abstract:To search the cytogenctic mechanism of adverse pregnancy,a study was carried out on 110 couples,57 of them with unexplained adverse pregnancy and 57 served as a control.A technique for the simultaneous staining of both nucleolar organizer regions and kinetochores of human chromosomes with silver was used.The results showed that the variations of chromosomal centromere kinetochore complex (CKC) in couples with adverse pregnancy were significantly high than of the control.The variations of CKC may be the main reason for the chromosomal nondisjunction during meiosis that is attributed to the adverse pregnancy.     

应用荧光原位杂交检测人凝血因子Ⅸ在转基因小鼠染色体上的整合

应用荧光原位杂交（FISH）技术检测两个转基因小鼠家系从F1到F4代的整合情况。阳性转基因小鼠98%~100%的中期分裂相,85%~94%的间期核出现杂交信号;阴性对照小鼠100%的中期分裂相、95%~96%的间期核未出现杂交信号。结果表明,该FISH实验条件能对转基因整合位点进行高效特异检测。本文分析的两家系转基因小鼠均为单位点整合, 但整合位点不同。各家系内F1到F4代的转基因小鼠均可检出整合染色体,且整合位点相同,表明外源基因稳定整合并遗传给后代。 Abstract:Fluorescence in situ hybridization （FISH） was used to detect the integration of hFⅨ on chromosomes of transgenic mice from F1 to F4 generation in two strains.For transgenic mice,98%~100% of metaphases and 85%~94% of interphases showed hybridization signal.For negative control mice,100% of metaphases and 95%~96% of interphases showed no hybridization signal.The results demonstrated that FISH developed to detect the integration sites of hFⅨ was high efficient and specific.The integration sites of the transgenic mice analyzed were both single but different between the two strains.The integration chromosomes can be found in the transgenic mice from F1 to F4 generation and the integration sites were the same as each of the strains,which indicated that the transgene was stably integrated and transmitted to offspring.     

贵州地区汉族人群THO1、TPOX、CSF1PO基因座的遗传多态性

为了解贵州地区汉族群体中THO1、TPOX、CSF1PO基因座的遗传多态性,获得这3个基因座的群体遗传学数据和法医学相关数据。采自贵州地区汉族无关个体的110份EDTA抗凝血样用Chelex法提取DNA,应用PCR复合扩增技术扩增样本后,聚丙烯酰胺凝胶电泳分型。对3个STR基因座的等位基因频率进行了调查分析,并与其他汉族人群的等位基因频率进行了比较。在贵州汉族群体中,3个基因座的基因型分布符合Hardy-Weinberg平衡。3个STR基因座总个体识别率为0.9986,累积非父排除率为0.832。表明这3个基因座在法医学个体识别及亲子鉴定中是很有价值的遗传标记系统。 Abstract:To understand the genetic polymorphism at THO1,TPOX,CSF1PO STR loci for Han population in Guizhou Province,and construct a preliminary database,EDTA-blood specimens were collected from the 110 unrelated individuals in Han population from Guizhou.The DNA samples were extracted with Chelex method and amplified by multiplex polymerase chain reaction.The PAGE was used to type the PCR products.The allele frequencies were compared with other Han populations.The genotype distributions of THO1,TPOX and CSF1PO were in accordance with Hardy-Weinberg equilibrium.The combined PD and PE were 0.9986 and 0.832 respectively.All of the three loci in this study provide useful marker for forensic paternity test and individual identification.     

Preimplantation Genetic Diagnosis for Aneuploidy and Translocations Using Array Comparative Genomic Hybridization

At least 50% of human embryos are abnormal, and that increases to 80% in women 40 years or older. These abnormalities result in low implantation rates in embryos transferred during in vitro fertilization procedures, from 30% in women <35 years to 6% in women 40 years or older. Thus selecting normal embryos for transfer should improve pregnancy results. The genetic analysis of embryos is called Preimplantation Genetic Diagnosis (PGD) and for chromosome analysis it was first performed using FISH with up to 12 probes analyzed simultaneously on single cells. However, suboptimal utilization of the technique and the complexity of fixing single cells produced conflicting results. PGD has been invigorated by the introduction of microarray testing which allows for the analysis of all 24 chromosome types in one test, without the need of cell fixation, and with staggering redundancy, making the test much more robust and reliable. Recent data published and presented at scientific meetings has been suggestive of increased implantation rates and pregnancy rates following microarray testing, improvements in outcome that have been predicted for quite some time. By using markers that cover most of the genome, not only aneuploidy can be detected in single cells but also translocations. Our validation results indicate that array CGH has a 6Mb resolution in single cells, and thus the majority of translocations can be analyzed since this is also the limit of karyotyping. Even for translocations with smaller exchanged fragments, provided that three out of the four fragments are above 6Mb, the translocation can be detected.     

Preimplantation genetic diagnosis in Saudi Arabia

Preimplantation genetic diagnosis (PGD) testing is the practice of obtaining a cellular biopsy sample from a developing human oocyte or embryo, acquired via a cycle of in vitro fertilization (IVF); evaluating the genetic composition of this sample; and using this information to determine which embryos will be optimal for subsequent uterine transfer. PGD has become an increasingly useful adjunct to IVF procedures. The ability to provide couples who are known carriers of genetic abnormalities the opportunity to deliver healthy babies has opened a new frontier in reproductive medicine. The purpose of the PGD is enables us to choose which embryos will be implanted into the mother. In the present study 137 families who had undergone IVF at Habib Medical Centre, were enrolled for the PGD analysis. The couple visited the clinic for the sex selection, recurrent fetal loss and with the recurrent IVF failure. 802 embryos were tested by the biopsy method and 512 are found to be normal and 290 were abnormal embryos. In this study only 24% of the embryos were transferred and the remaining was not transferred because of the abnormalities or undesired sex of the embryos. The structural and numerical abnormalities were found to be 16.8%.     

脆性X综合征的基因诊断与产前诊断

为了探讨简便、快速、准确、价廉的脆性X综合征的诊断方法,对6个智能低下家系进行了细胞遗传学检查,以及PCR直接扩增FMR1 5^'端(CGG)_{n<\sub>重复序列、RT-PCR扩增FMR1基因的cDNA序列的分子遗传学检查。A家系先证者脆性X染色体高表达（35/273）,分子遗传学检查证实为脆性X综合征全突变患者;B家系先证者及其母亲无脆性X染色体表达,分子遗传学检查证实为非脆性X综合征患者;C家系的男性胎儿脆性X染色体表达（5/93）,先证者及其母亲未发现脆性X染色体,分子遗传学检查证实男性胎儿为脆性X综合征全突变患者,其母亲为前突变携带者,哥哥为嵌合体患者;D家系先证者脆性X染色体高表达17%,其姐姐脆性X染色体5%,分子遗传学检查证实先证者为脆性X综合征全突变患者,其姐姐为嵌合体患者;E家系先证者及其母亲,F家系先证者发现可疑脆性X染色体,分子遗传学检查证实为非脆性X综合征家系。结论： PCR直接扩增FMR1基因(CGG)n<\sub>重复序列联合RT-PCR扩增FMR1基因cDNA 序列简便、快速、价廉。可用于脆性X综合征的筛查、诊断及产前诊断,有推广应用价值。}     

MDA-DHPLC技术在PGS中的应用

目的:评估丙二醛变性高效液相色谱法在胚胎移植过程中的临床价值。方法:收集我院生殖中心2010年2月~2012年3间未做移植的废弃胚胎,由D2胚胎培养到D3胚胎期,提取遗传物质并进行PRC扩增,采用高形态学评分的D3作为对照,高效液相色谱法测定遗传DNA过氧化产物丙二醛(MDA)的含量。结果:多核Ⅰ组D2期卵裂球核≥2个,共24枚胚胎,DNA过氧化产物丙二醛(MDA)的含量5.32±0.19μmol/L,对比正常胚胎0.67±0.08μmol/l有显著差异(P0.05)。多核Ⅱ组D2期卵裂球核=2,共19枚胚胎,MDA的含量4.12±0.22μmol/L,对比正常胚胎0.67±0.08μmol/l有显著差异(P0.05)。Ⅰ组与Ⅱ组间没有统计学差异。然而,空泡胚胎与非空泡胚胎之间MDA并没有差异。结论:多核D2期胚胎培养到D3期会产生很高异常率,因此临床上应减少使用此种进行移植。     

Review: Preimplantation genetic diagnosis (PGD) as a reproductive option in patients with neurodegenerative disorders

Preimplantation genetic diagnosis (PGD) was introduced in the late 1980s and represents an option for couples at risk of transmitting an inherited, debilitating or neurological disorder to their children. From a cleavage or blastocyst stage embryo, cell(s) are collected and then genetically analyzed for disease; enabling an unaffected embryo to be transferred into the uterus cavity. Nowadays, PGD has been carried out for several hundreds of heritable conditions including myotonic dystrophy, and for susceptibility genes involved in cancers of the nervous system. Currently, advanced molecular technologies with better resolution, such as array comparative genomic hybridisation, quantitative polymerase chain reaction, and next generation sequencing, are on the verge of becoming the gold standard in embryo preimplantation screening. Given this, it may be time for neurological societies to consider the published evidence to develop new guidelines for the integration of PGD into modern preventative neurology. Therefore, the main aim of this review is to illustrate the option of PGD to enable conception of an unaffected baby, and to assist clinicians and neurologists in the counseling of the patient at risk of transmitting an inherited disease, to explore the genetic journey throughout in vitro fertilization IVF with PGD.     

小鼠单卵裂球体外培养及染色体制备

为了探索研究了植入前胚胎染色体病（包括平衡易位）诊断的可行性方法,作者进行了单卵裂球体外培养、染色体制备及显带技术研究,在Ｂ２培养基加血清进行培养的基础上,比较了在两种没处理因素进行体外培养时小鼠单卵裂球增殖情况,Ｂ２培养基加血清再加输卵管包埋进行培养,其单卵裂球体外增殖率为５０％（８７／１７４）,单卵裂球染色体制备成功率为２７．６％;Ｂ２培养基加腹水过滤液进行培养,其单卵裂球体外增殖率为３３％（     

分子生物学技术在遗传病诊断中的应用

论述了遗传性疾病的发病机理和遗传病诊断的途径和策略,着重介绍了人类遗传疾病基因诊断技术的原理和发展状况,对该领域的新成果作了介绍和总结,对发展动向和存在的问题作了简要论述。 Abstract:The mechanisms of human genetic diseases and strategies to test human genetic diseases are discussed in the review.The development of the gene diagnosis techniques to genetic diseases and their principles are introduced emphatically.The new achievements in the field are valued and concluded,and the prospect and the difficulties in genetic diseases diagnosis are also briefly discussed.